These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 30849939)

  • 1. Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report.
    Liu Y; Wang X; Zhu M; Xu G; Li L
    BMC Ophthalmol; 2019 Mar; 19(1):68. PubMed ID: 30849939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y; Li L; Xu G; Wang W
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
    Lee CS; Woo SJ; Kim YK; Hwang DJ; Kang HM; Kim H; Lee SC
    Ophthalmology; 2014 May; 121(5):1029-35. PubMed ID: 24439757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
    Zhang Z; Bao X; Wu Z; Zhang J
    Medicine (Baltimore); 2021 Feb; 100(7):e24790. PubMed ID: 33607835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization.
    Hu YC; Chen YL; Chen YC; Chen SN
    Sci Rep; 2021 Jun; 11(1):13286. PubMed ID: 34168238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY.
    Peiretti E; Caminiti G; Serra R; Querques L; Pertile R; Querques G
    Retina; 2018 Aug; 38(8):1526-1532. PubMed ID: 28699928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
    Sheptulin V; Purtskhvanidze K; Roider J
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2027-2034. PubMed ID: 30097783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L; Lin B; Hong J; Min HB; Han WL; Zhou TY; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical correlates of focal choroidal excavation in eyes with age-related macular degeneration, polypoidal choroidal vasculopathy and central serous chorioretinopathy.
    Lim FP; Wong CW; Loh BK; Chan CM; Yeo I; Lee SY; Mathur R; Wong D; Wong TY; Cheung CM
    Br J Ophthalmol; 2016 Jul; 100(7):918-923. PubMed ID: 26504178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy.
    Liu HY; Yang CH; Yang CM; Ho TC; Lin CP; Hsieh YT
    Am J Ophthalmol; 2016 Jul; 167():57-64. PubMed ID: 27084002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].
    Li L; Yuan F; Xu GZ; Wang WJ
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):106-13. PubMed ID: 22490944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in the treatment of choroidal neovascularization complicating central serous chorioretinopathy.
    Yang CS; Chen KC; Lee SM; Lee FL
    J Chin Med Assoc; 2009 Sep; 72(9):501-5. PubMed ID: 19762322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
    Chan WM; Lam DS; Lai TY; Yuen KS; Liu DT; Chan CK; Chen WQ
    Am J Ophthalmol; 2003 Nov; 136(5):836-45. PubMed ID: 14597034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.